← FDA Drug Approvals (Drugs@FDA)

ROPIVACAINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2014-09-23

Drug application

FDA Application #

ANDA090194

Application type

Abbreviated New Drug Application (Generic)

Brand name

ROPIVACAINE HYDROCHLORIDE

Generic name

Ropivacaine Hydrochloride

Active ingredients

ROPIVACAINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INJECTION

Marketing status

Discontinued

Sponsor

HOSPIRA

First approval

2014-09-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown